United Inernet reinvested in the location data management platform, which doubled its series B round to $50m in the transaction.
Month: September 2018
OncoResponse answers questions with $40m series B
Helsinn Investment Fund and Alexandria Venture Investments both invested as OncoResponse looks to advance five immuno-oncology drug candidates.
Cigna makes Cricket match in $24m series A
Cricket Health, developer of an integrated kidney care service that helps patients stay out of hospital, has completed an Oak HC/FT-led series A round.
ShipBob handles $40m series C delivery
Recruit-backed e-commerce fulfilment services provider ShipBob increased its total funding to more than $62m in a round led by Menlo Ventures.
Benson Hill reaps $60m in series C
GV led Benson Hill Biosystems’ latest round, which increased the total raised by the crop specification technology provider to more than $94m.
Ctrip sets $100m course for Zomato
The online travel booking platform is in talks to invest $100m as part of a $400m round that will value the restaurant listings platform at up to $2bn.
Twentyeight-Seven counts down to $65m series A
Novartis Venture Fund, a founding investor, co-led a $65m series A round to launch cancer treatment developer Twentyeight-Seven Therapeutics.
MasterClass addresses $80m series D
Evolution Media has put its weight behind MasterClass, an online education provider already backed by Bloomberg and Novel Group.
Dream11 wakes up to $100m series D
Tencent has led a $100m series D round for fantasy sports company Dream11, a deal that was first rumoured in April this year.
Acorn OakNorth reaches for $100m
NIBC Bank has contributed to a $100m funding round for lender Acorn OakNorth, which is now valued at $2.3bn.
Branch to spread into $129m series D
Samsung-backed Branch is raising $129m at a valuation of at least $1bn, though investors have not yet been revealed.
Guardant Health to chaperon shares to Nasdaq
Guardant Health is targeting $100m in proceeds for its initial public offering on the Nasdaq Global Select Market, which would offer an exit to SoftBank.
Eventbrite sets price range of IPO admission
Square-backed event ticketing management platform Eventbrite will price its shares between $19 and $21 and could raise up to a total of more than $241m when it goes public.
Augmenix gels with Boston Scientific for $600m
Boston Scientific will pay $500m upfront and up to $100m in milestone payments to acquire Augmenix, providing exits to Varian Medical Systems and Ascension Health.